Robert Hogg
Robert Hogg
Faculty of Health Sciences, Simon Fraser University
Verified email at sfu.ca - Homepage
TitleCited byYear
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies
M Egger, M May, G ChÍne, AN Phillips, B Ledergerber, F Dabis, ...
The Lancet 360 (9327), 119-129, 2002
18462002
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global†…
H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta, A Carter, DC Casey, ...
The lancet 388 (10053), 1459-1544, 2016
17302016
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.
TCC Antiretroviral
Lancet 372 (9635), 293, 2008
15532008
Effect of early versus deferred antiretroviral therapy for HIV on survival
MM Kitahata, SJ Gange, AG Abraham, B Merriman, MS Saag, AC Justice, ...
New England Journal of Medicine 360 (18), 1815-1826, 2009
14152009
Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
RS Hogg, KV Heath, B Yip, KJP Craib, MV O'shaughnessy, MT Schechter, ...
Jama 279 (6), 450-454, 1998
9711998
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies
When To Start Consortium
The Lancet 373 (9672), 1352-1363, 2009
9302009
Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada
H Samji, A Cescon, RS Hogg, SP Modur, KN Althoff, K Buchacz, ...
PloS one 8 (12), 2013
9162013
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy
RS Hogg, B Yip, KJ Chan, E Wood, KJP Craib, MV O'Shaughnessy, ...
Jama 286 (20), 2568-2577, 2001
9102001
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
JSG Montaner, VD Lima, R Barrios, B Yip, E Wood, T Kerr, K Shannon, ...
The Lancet 376 (9740), 532-539, 2010
8112010
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic
JSG Montaner, R Hogg, E Wood, T Kerr, M Tyndall, AR Levy, PR Harrigan
The Lancet 368 (9534), 531-536, 2006
5962006
Causes of death in HIV-1–infected patients treated with antiretroviral therapy, 1996–2006: Collaborative analysis of 13 HIV cohort studies
ATC Collaboration
Clinical infectious diseases: an official publication of the Infectious†…, 2010
5412010
Barriers to use of free antiretroviral therapy in injection drug users
SA Strathdee, A Palepu, PGA Cornelisse, B Yip, MV O'Shaughnessy, ...
Jama 280 (6), 547-549, 1998
5171998
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy
PR Harrigan, RS Hogg, WWY Dong, B Yip, B Wynhoven, J Woodward, ...
The Journal of infectious diseases 191 (3), 339-347, 2005
4752005
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up
RS Hogg, K Heath, D Bangsberg, B Yip, N Press, MV O'Shaughnessy, ...
Aids 16 (7), 1051-1058, 2002
4542002
Decline in deaths from AIDS due to new antiretrovirals
RS Hogg, MV O'Shaughnessy, N Gataric, B Yip, K Craib, MT Schechter, ...
The Lancet 349 (9061), 1294, 1997
4371997
Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350◊ 109 cells/L
E Wood, RS Hogg, B Yip, PR Harrigan, MV O'Shaughnessy, ...
Annals of internal medicine 139 (10), 810-816, 2003
4302003
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda
EJ Mills, C Bakanda, J Birungi, K Chan, N Ford, CL Cooper, JB Nachega, ...
Annals of internal medicine 155 (4), 209-216, 2011
4242011
Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens
RS Hogg, B Yip, C Kully, KJP Craib, MV O'Shaughnessy, MT Schechter, ...
Cmaj 160 (5), 659-665, 1999
3831999
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies
Antiretroviral Therapy (ART) Cohort Collaboration
AIDS (London, England) 21 (9), 1185, 2007
3822007
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study
E Wood, T Kerr, BDL Marshall, K Li, R Zhang, RS Hogg, PR Harrigan, ...
Bmj 338, b1649, 2009
3582009
The system can't perform the operation now. Try again later.
Articles 1–20